• Your Local Fayetteville and Elizabethtown Area Eye Experts

Valeda Dry AMD Treatment in Fayetteville | Carolina Vision Center

Valeda Dry AMD Treatment in Fayetteville | Carolina Vision Center

[vc_row tm_bgimagefixed=”” full_width=”stretch_row” css=”.vc_custom_1746452948620{margin-top: -150px !important;padding-top: 200px !important;padding-bottom: 200px !important;background-image: url(https://carolinavisioncenter.com/wp-content/uploads/2025/04/valeda-hero-optimized.jpg?id=6579) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column tm_textcolor=”white” css=”.vc_custom_1746044848629{background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_text css=””]

Valeda Light Therapy:
Dry AMD Treatment
in Fayetteville, NC

[/vc_column_text][vc_btn title=”Schedule a Consultation” style=”custom” custom_background=”#0d4a8f” custom_text=”#ffffff” shape=”round” align=”left” css=”” link=”url:https%3A%2F%2Fpromptlybyfph.com%2Fpromptly%2Fwebapp%2F%23%2Fpublic%3Fcode%3Dcarvis|target:_blank”][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”6513″ img_size=”Medium” alignment=”center” css=””][vc_column_text css=”” el_class=”lead”]

A Breakthrough in Dry AMD Treatment Now Available at Carolina Vision Center

Valeda Light Therapy is the first and only FDA-approved treatment for Dry Age-Related Macular Degeneration (Dry AMD). Now available at Carolina Vision Center, Valeda uses photobiomodulation therapy—a non-invasive, pain-free light treatment—to stimulate cellular energy, reduce drusen, slow disease progression, and help preserve central vision. This breakthrough technology offers new hope for patients diagnosed with Dry AMD who previously had no treatment options.

Carolina Vision Center is the only medical facility in Eastern North Carolina offering the FDA-approved treatment for dry macular degeneration.[/vc_column_text][vc_column_text]

[/vc_column_text][/vc_column][vc_column][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css=””]

A New Hope for Dry AMD

First and only Dry AMD Treatment – Now available[/vc_column_text][vc_column_text css=””]• FDA-approved light therapy
• Stimulates retinal cells
• Non-invasive and painless

Valeda uses multiple wavelengths of light to activate cellular regeneration in the retina.[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_single_image image=”6508″ img_size=”medium” alignment=”center” css=””][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=””]

What is Valeda?

Valeda uses specific wavelengths of light (590, 660, and 850 nm) to stimulate cellular repair, reduce inflammation, and enhance mitochondrial function. This innovative therapy targets the root causes of dry AMD, such as oxidative damage and cellular dysfunction, to preserve vision and improve eye health. Stated another way, it puts more energy into the regenerative cell repair while decreasing the harmful effects of inflammation which can hasten cell death. Remember, 85-90% of macular degeneration is Dry AMD.  If you act now, you may be able to preserve or even improve your sight.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css=””]

How Valeda Works

[/vc_column_text][vc_column_text css=””]Valeda delivers light therapy in four phases during each session:

  • Phase 1: 590 and 850 nm pulsed light (35 seconds, eyes open).
  • Phase 2: 660 nm continuous light (90 seconds, eyes closed).
  • Phase 3: 590 and 850 nm pulsed light (35 seconds, eyes open).
  • Phase 4: 660 nm continuous light (90 seconds, eyes closed).

Each session lasts approximately 4 minutes and 10 seconds and is completely non-invasive. [/vc_column_text][/vc_column][vc_column width=”1/2″][vc_single_image image=”6615″ img_size=”full” onclick=”link_image” css=””][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/3″][vc_icon icon_fontawesome=”fas fa-bolt” color=”turquoise” size=”lg”][vc_column_text]Boosts mitochondrial activity for retinal repair.[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][vc_icon icon_fontawesome=”fas fa-lightbulb” color=”turquoise” size=”lg”][/vc_column_inner][vc_column_inner width=”1/3″][vc_icon icon_fontawesome=”fas fa-eye” color=”turquoise” size=”lg”][vc_column_text]Supports better contrast and sharper vision.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner][vc_raw_html css=””]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[/vc_raw_html][vc_column_text]Red, yellow, and NIR light reduce inflammation.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_column_text css=””]Treatment Process

A Treatment Series: Nine (9) sessions delivered 3 times per week over 3–5 weeks.

Frequency: Treatment series are repeated every 4 months.

No Pupil Dilation Required: Sessions are straightforward and require minimal preparation.

[/vc_column_text][vc_column_text css=””]Clinical Benefits

Improved Visual Acuity:

Gain in visual acuity was documented in the average patient and lasted over two years (end of study measurements)

In this study, patients who had more significant visual impairment in the beginning experienced greater improvement compared to those who had better visual acuity initially.

Reduction in Disease Progression:

Slows the development of geographic atrophy (GA) and reduces macular drusen volume.

Enhanced Quality of Life:

Better near vision and improved ability to perform daily activities like reading.

[/vc_column_text][vc_column_text css=””]Safety Profile

  • Non-Invasive: Valeda uses LED light, not lasers, ensuring no thermal treatment or local cellular damage.
  • No Serious Adverse Events: Clinical trials report no phototoxicity (damage to light-sensitive cells) or harmful side effects.
  • Eye-Safe: Meets ANSI Z80.36 and IEC 62471 standards for light exposure safety.

[/vc_column_text][vc_separator color=”chino” style=”dotted” border_width=”5″ css=””][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css=””]

Is Valeda Right for You?

[/vc_column_text][vc_column_text]
• Early to intermediate Dry AMD
• Experiencing central vision distortion
• Prefer a non-surgical option
• Have stable general eye health
[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text css=””]Learn about Valeda, the first and only FDA-cleared light-based treatment for Dry Age-Related Macular Degeneration (AMD). This brochure explains symptoms, how the therapy works, and who may benefit. Early diagnosis and treatment with Valeda can help preserve vision and improve retinal health.[/vc_column_text][vc_btn title=”Download the Patient Brochure” style=”custom” custom_background=”#28439B” custom_text=”#E6E6E6″ shape=”round” align=”center” css=”” link=”url:https%3A%2F%2Fcarolinavisioncenter.com%2Fwp-content%2Fuploads%2F2025%2F05%2FMKT-0113-enUS-REV-B-VAL-Patient-Brochure-column-page.pdf|target:_blank”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=””]

Who is Eligible for Valeda?

Valeda is designed for patients with:

  • Best Corrected Visual Acuity (BCVA): Between 20/32 and 20/70.
  • Dry AMD Characteristics: 
    • Presence of medium or large drusen. (see picture below for what drusen looks like under the “Visual Evidence” section below)
    • Non-central geographic atrophy.
  • No Neovascular Maculopathy: Patients with uncontrolled wet AMD or center-involving GA are generally not good candidates for treatment. Each case is unique, and we recommend you see us for a thorough evaluation and our recommendations.
  • Other “off-label” Benefits: non-central wet AMD, well-controlled early wet AMD, diabetic macular edema, select cases of graphic atrophy (GA), mixed dry and wet AMD, central serous chorioretinopathy. These possible treatments are evaluated individually, followed by a discussion with each patient. See example of central serous chorioretinopathy under the second “Visual Evidence” heading below.

[/vc_column_text][vc_column_text css=””]

Find out if you are a candidate today!

[/vc_column_text][vc_btn title=”Schedule an Appointment Today!” style=”custom” custom_background=”#28439B” custom_text=”#E6E6E6″ shape=”round” align=”center” css=”” link=”url:https%3A%2F%2Fpromptlybyfph.com%2Fpromptly%2Fwebapp%2F%23%2Fpublic%3Fcode%3Dcarvis|title:Patient%20Portal|target:_blank”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=””]

LumiThera Valeda: Clinical Results

[/vc_column_text][vc_column_text css=””]Valeda has shown up to 7-letter improvements in visual acuity in clinical trials. Over 70% of treated eyes experienced vision improvement or stabilization, with zero serious adverse events.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=””]

Visual Evidence

[/vc_column_text][vc_column_text css=””]Representative OCT images show a significant reduction in macular drusen volume after PBM treatment, with no loss of photoreceptor or retinal pigment epithelium.[/vc_column_text][vc_row_inner][vc_column_inner width=”1/2″][vc_single_image image=”6610″ img_size=”Large” alignment=”center” onclick=”link_image” css=”.vc_custom_1746463474579{background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}”][vc_column_text css=””]

This image series showcases Optical Coherence Tomography (OCT) scans of a patient with Dry Age-Related Macular Degeneration (Dry AMD) undergoing treatment with the FDA-approved Valeda Light Delivery System.

  • Baseline: Significant macular elevation and fluid are present.

  • Week 1 (3 PBM Treatments): Early reduction in elevation and fluid accumulation.

  • Week 3 (9 PBM Treatments): Continued flattening and retinal layer normalization.

  • Follow-up (~1 year): Sustained improvement with restored foveal contour and reduced retinal swelling.

The results highlight the potential long-term benefits of photobiomodulation therapy (PBM) in managing Dry AMD.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/2″][vc_single_image image=”6612″ img_size=”full” alignment=”center” onclick=”link_image” css=”.vc_custom_1746477368918{padding-bottom: 135px !important;}”][vc_column_text css=””]

This image shows two Optical Coherence Tomography (OCT) scans of a patient with Dry Age-Related Macular Degeneration (Dry AMD) undergoing Valeda Light Delivery System treatment.

  • The left scan captures significant macular swelling and fluid pockets beneath the retinal layers prior to treatment.

  • The right scan shows the same eye after a series of photobiomodulation (PBM) therapy sessions with Valeda, demonstrating reduced fluid, improved macular contour, and enhanced retinal structure.

[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=””]

What to Expect During Treatment

[/vc_column_text][vc_toggle title=”How long does each session take?”]Each Valeda treatment lasts about 20 minutes.[/vc_toggle][vc_toggle title=”Is the treatment painful?”]Not at all. Most patients find it relaxing.[/vc_toggle][vc_toggle title=”How many treatments are required?”]Typically 9 sessions over 3–4 weeks.[/vc_toggle][/vc_column][/vc_row][vc_row][vc_column][vc_custom_heading text=”Schedule Your Consultation Today” font_container=”tag:h2|text_align:center”][vc_column_text css=””]

Don’t wait to protect your vision.

[/vc_column_text][vc_btn title=”Schedule an Appointment Today!” style=”custom” custom_background=”#28439B” custom_text=”#E6E6E6″ shape=”round” align=”center” css=”” link=”url:https%3A%2F%2Fpromptlybyfph.com%2Fpromptly%2Fwebapp%2F%23%2Fpublic%3Fcode%3Dcarvis|title:Patient%20Portal|target:_blank”][vc_empty_space height=”150″][/vc_column][/vc_row][vc_row][vc_column][vc_custom_heading text=”Frequently Asked Questions”][vc_toggle title=”Is Valeda covered by insurance?”]Currently, it’s not covered, but payment options are available.[/vc_toggle][vc_toggle title=”Does it hurt?”]No. It’s completely painless.[/vc_toggle][vc_toggle title=”When will I notice results?”]Some report improvements within a few sessions.[/vc_toggle][vc_toggle title=”How long are the sessions?”]About 20 minutes.[/vc_toggle][vc_toggle title=”How many will I need?”]Typically 9 treatments over 3–4 weeks.[/vc_toggle][/vc_column][/vc_row][vc_row][vc_column][vc_raw_html css=””]JTNDYSUyMGhyZWYlM0QlMjJodHRwcyUzQSUyRiUyRnd3dy5jYXJlY3JlZGl0LmNvbSUyRmdvJTJGNTQ1V05IJTJGJTNGZHRjJTNERFM5WCUyNnNpdGVjb2RlJTNEQ0NMQkFEUzlYJTIyJTNFJTNDaW1nJTIwd2lkdGglM0QlMjIyNzUlMjIlMjBzdHlsZSUzRCUyMm1heC13aWR0aCUzQTEwMCUyNSUzQiUyMiUyMHNyYyUzRCUyMmh0dHBzJTNBJTJGJTJGd3d3LmNhcmVjcmVkaXQuY29tJTJGc2l0ZXMlMkZwYyUyRmltYWdlJTJGZmxleGlibGUtZmluYW5jaW5nLXByZXF1YWwtMzc1eDMyMC5wbmclMjIlMkYlM0UlM0MlMkZhJTNF[/vc_raw_html][/vc_column][/vc_row]